Niga-ichigoside F1
CAS: 95262-48-9
Ref. 3D-VDA26248
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
- 19α-Hydroxyasiatic acid 28-O-β-<span class="text-smallcaps">D</span>-glucopyranoside
- 19α-Hydroxyasiatic acid β-<span class="text-smallcaps">D</span>-glucopyranosyl ester
- Dotorioside II
- DotoriosideII
- Laevigatanoside A
- Niga-ichigoside F 1
- Urs-12-en-28-oic acid, 2,3,19,23-tetrahydroxy-, β-<span class="text-smallcaps">D</span>-glucopyranosyl ester, (2α,3β,4α)-
Niga-ichigoside F1 is an antidiabetic agent that is extracted from the bark of a tree in the genus Niga. It has been shown to decrease the blood glucose level by increasing the production of insulin, suppressing gluconeogenesis, and inhibiting glycogenolysis. Niga-ichigoside F1 also contains triterpenoid saponins that are known to have anti-inflammatory properties. This drug has been used as a treatment for various types of cancer, such as skin cancer and breast cancer. Niga-ichigoside F1 may also be beneficial in preventing cisplatin-induced nephrotoxicity and hepatic steatosis.
Propiedades químicas
Consulta técnica sobre: 3D-VDA26248 Niga-ichigoside F1
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
